Ruxolitinib (INCB018424) in Participants With Primary Myelofibrosis (PMF), Post Essential Thrombocythemia-myelofibrosis and Post Polycythemia Vera-myelofibrosis (PPV-MF)
Clinical trial NCT01348490 · COMPLETED
Trial details
- NCT number
- NCT01348490
- Sponsor
- Incyte Corporation
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-06-15
- Primary completion
- 2018-12-19
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.